secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2023-07-31T23:59:59+00:00
Accession:  0001425450-23-000098
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q2 revenue $39.6M (+20% YoY); net loss $2.9M, FY guide reaffirmed
--------------------------------------------------------------------------------

- Total revenue $39.6M, +20% vs $32.9M in Q2 2022; US +19%, international +25%.
- Trauma & Deformity revenue $27.5M (+22%), Scoliosis $10.9M (+16%), Sports Med/Other $1.2M (+23%).
- Gross margin 76% (flat YoY); operating expenses $35.6M (+24%).
- Net loss $2.9M ($0.13 loss per share) vs $0.3M loss a year ago; adj. EBITDA $2.3M vs $2.1M.
- FY 2023 revenue guidance reiterated at $148M–$151M (21–23% growth); adj. EBITDA expected $3M–$4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000098/0001425450-23-000098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000098/kids-20230731.htm
  HTML page:      https://secwatch.observer/filing/0001425450-23-000098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer